Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial

Lignende værker

• Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS
  af: Tao, Yazhong, et al.
  Udgivet: (2015)
• Effect of Treatment with Interferon Beta-1a on Changes in Voxel-Wise Magnetization Transfer Ratio in Normal Appearing Brain Tissue and Lesions of Patients with Relapsing–Remitting Multiple Sclerosis: A 24-Week, Controlled Pilot Study
  af: Zivadinov, Robert, et al.
  Udgivet: (2014)
• A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing–remitting multiple sclerosis
  af: Robert Zivadinov, et al.
  Udgivet: (2015-03-01)
• A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing–remitting multiple sclerosis
  af: Zivadinov, Robert, et al.
  Udgivet: (2015)
• Comparison of Standard 1.5 T vs. 3 T Optimized Protocols in Patients Treated with Glatiramer Acetate. A Serial MRI Pilot Study
  af: Zivadinov, Robert, et al.
  Udgivet: (2012)